Secretory Carcinoma of the Parotid: Making the Correct Diagnosis of a Rare Salivary Gland Carcinoma When Molecular Biology Testing Is Not Available

Secretory carcinoma (SC) is a recently described entity occurring in the salivary glands. Before its description, SC was frequently classified as acinic cell carcinoma (ACC) or adenocarcinoma, not otherwise specified. Its particular histopathological and immunohistochemical characteristics are remin...

Full description

Saved in:
Bibliographic Details
Main Authors: Nelson Montalvo, David Galarza, Ligia Redrobán
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Case Reports in Pathology
Online Access:http://dx.doi.org/10.1155/2019/5103496
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841524419928784896
author Nelson Montalvo
David Galarza
Ligia Redrobán
author_facet Nelson Montalvo
David Galarza
Ligia Redrobán
author_sort Nelson Montalvo
collection DOAJ
description Secretory carcinoma (SC) is a recently described entity occurring in the salivary glands. Before its description, SC was frequently classified as acinic cell carcinoma (ACC) or adenocarcinoma, not otherwise specified. Its particular histopathological and immunohistochemical characteristics are reminiscent of breast secretory carcinoma. Moreover, it displays a characteristic t(12;15) (p13;q25) translocation that results in the ETV6-NTRK3 gene fusion. This translocation has not been reported in any other salivary gland carcinoma. Identification of the t(12;15) (p13;q25) translocation is the gold standard for diagnosis, although some cases that do not present this specific translocation have already been reported. In such cases, diagnosis is challenging. In addition, some diagnostic pathology laboratories lack the resources to perform the molecular analysis to diagnose SC. In this scenario, morphology and immunohistochemistry are fundamental. Therefore, we report a case emphasizing the typical morphology of SC and its immunochemical profile to establish a final diagnosis without molecular biology tests. This case aims to demonstrate the importance of recognizing the typical presentation of a rare tumor so that clinicians will be informed or reminded of it and consider this entity among the differential diagnoses, when necessary. Moreover, in low-resource settings where molecular analysis is not available, being familiar enough with the histology of this tumor and using the immunoprofile as a key tool for differential diagnosis would be of great importance in establishing the correct diagnosis. The differential diagnosis includes, above all, acinic cell carcinoma and other salivary neoplasms such as intraductal carcinoma, low-grade mucoepidermoid carcinoma, and adenocarcinoma, not otherwise specified, which is actually a rule-out diagnosis.
format Article
id doaj-art-ceea7148d36b4aa396b5c7e45484d7a6
institution Kabale University
issn 2090-6781
2090-679X
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Case Reports in Pathology
spelling doaj-art-ceea7148d36b4aa396b5c7e45484d7a62025-02-03T05:53:20ZengWileyCase Reports in Pathology2090-67812090-679X2019-01-01201910.1155/2019/51034965103496Secretory Carcinoma of the Parotid: Making the Correct Diagnosis of a Rare Salivary Gland Carcinoma When Molecular Biology Testing Is Not AvailableNelson Montalvo0David Galarza1Ligia Redrobán2Facultad de Ciencias Médicas de la Salud y la Vida, Escuela de Medicina, Área de Ciencias Básicas, Cátedra de Patología, Universidad Internacional del Ecuador. Servicio de Patología, Hospital Metropolitano. Av. Mariana de Jesús s/n y Nicolás Arteta. Quito, EcuadorFacultad de Ciencias Médicas de la Salud y la Vida, Escuela de Medicina, Docencia y Departamento de Investigación, Universidad Internacional del Ecuador, EcuadorServicio de Patología, Hospital Metropolitano, EcuadorSecretory carcinoma (SC) is a recently described entity occurring in the salivary glands. Before its description, SC was frequently classified as acinic cell carcinoma (ACC) or adenocarcinoma, not otherwise specified. Its particular histopathological and immunohistochemical characteristics are reminiscent of breast secretory carcinoma. Moreover, it displays a characteristic t(12;15) (p13;q25) translocation that results in the ETV6-NTRK3 gene fusion. This translocation has not been reported in any other salivary gland carcinoma. Identification of the t(12;15) (p13;q25) translocation is the gold standard for diagnosis, although some cases that do not present this specific translocation have already been reported. In such cases, diagnosis is challenging. In addition, some diagnostic pathology laboratories lack the resources to perform the molecular analysis to diagnose SC. In this scenario, morphology and immunohistochemistry are fundamental. Therefore, we report a case emphasizing the typical morphology of SC and its immunochemical profile to establish a final diagnosis without molecular biology tests. This case aims to demonstrate the importance of recognizing the typical presentation of a rare tumor so that clinicians will be informed or reminded of it and consider this entity among the differential diagnoses, when necessary. Moreover, in low-resource settings where molecular analysis is not available, being familiar enough with the histology of this tumor and using the immunoprofile as a key tool for differential diagnosis would be of great importance in establishing the correct diagnosis. The differential diagnosis includes, above all, acinic cell carcinoma and other salivary neoplasms such as intraductal carcinoma, low-grade mucoepidermoid carcinoma, and adenocarcinoma, not otherwise specified, which is actually a rule-out diagnosis.http://dx.doi.org/10.1155/2019/5103496
spellingShingle Nelson Montalvo
David Galarza
Ligia Redrobán
Secretory Carcinoma of the Parotid: Making the Correct Diagnosis of a Rare Salivary Gland Carcinoma When Molecular Biology Testing Is Not Available
Case Reports in Pathology
title Secretory Carcinoma of the Parotid: Making the Correct Diagnosis of a Rare Salivary Gland Carcinoma When Molecular Biology Testing Is Not Available
title_full Secretory Carcinoma of the Parotid: Making the Correct Diagnosis of a Rare Salivary Gland Carcinoma When Molecular Biology Testing Is Not Available
title_fullStr Secretory Carcinoma of the Parotid: Making the Correct Diagnosis of a Rare Salivary Gland Carcinoma When Molecular Biology Testing Is Not Available
title_full_unstemmed Secretory Carcinoma of the Parotid: Making the Correct Diagnosis of a Rare Salivary Gland Carcinoma When Molecular Biology Testing Is Not Available
title_short Secretory Carcinoma of the Parotid: Making the Correct Diagnosis of a Rare Salivary Gland Carcinoma When Molecular Biology Testing Is Not Available
title_sort secretory carcinoma of the parotid making the correct diagnosis of a rare salivary gland carcinoma when molecular biology testing is not available
url http://dx.doi.org/10.1155/2019/5103496
work_keys_str_mv AT nelsonmontalvo secretorycarcinomaoftheparotidmakingthecorrectdiagnosisofararesalivaryglandcarcinomawhenmolecularbiologytestingisnotavailable
AT davidgalarza secretorycarcinomaoftheparotidmakingthecorrectdiagnosisofararesalivaryglandcarcinomawhenmolecularbiologytestingisnotavailable
AT ligiaredroban secretorycarcinomaoftheparotidmakingthecorrectdiagnosisofararesalivaryglandcarcinomawhenmolecularbiologytestingisnotavailable